Source: Contract Pharma

Cypex: BioIVT Acquires Scottish Drug-metabolizing Enzyme Manufacturer Cypex

Cypex's recombinant xenobiotic metabolizing enzymes complement BioIVT's portfolio of hepatocytes and related hepatic products.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
CEO Avatar

Director

Michael Voice

CEO Approval Rating

- -/100

Read more